Skip to main content

Author: Linxi Mytkolli

NEWS RELEASE: LAUNCH OF THE DIABETES ACTION CANADA NATIONAL DIABETES REPOSITORY

Diabetes Action Canada, part of the Canadian Institutes of Health Research SPOR Program in Chronic Disease, is thrilled to announce the launch of the National Diabetes Repository.

The National Diabetes Repository will be a major step forward in the monitoring and treatment of diabetes in Canada by enabling discovery through research in a secure and controlled environment.

The core elements of the repository will be created with Electronic Medical Record (EMR) data starting with existing primary care repositories in three provinces (Ontario – UTOPIAN; Alberta – NAPCReN and SAPCReN; Quebec – RRSPUM).  This represents data for over 50,000 patients with diabetes. Plans are underway to expand data holdings.

Diabetes Action Canada has oversight of the use of the data through a Research Governing Committee. 50% of the Research Governing Committee members are patients; members also include physicians providing EMR data, researchers with expertise in observational and clinical research and subject matter experts in research ethics, privacy and law.

The National Diabetes Repository will be available to Diabetes Action Canada Researchers.  The aims of the research include improving appropriate screening for complications and facilitating effective and timely intervention to ultimately improve the lives and health of Canadian living with diabetes.

Privacy and Security have been paramount in scoping the requirements for the Repository.  Rigorous privacy practices have been embedded into the foundation of the Repository and have been incorporated into all our policies and procedures.  This will allow us to provide access to researchers without compromising data security.  The National Diabetes Repository is managed at North York General Hospital and the physical hardware is housed at the Centre for Advanced Computing (CAC), a secure Compute Canada facility in Kingston, Ontario.

Submission Process:

Researchers will receive controlled access to the secure environment upon receiving approval from the Research Governance Committee.  The approval will be contingent on alignment with Diabetes Action Canada core values, research ethics approval and confirmation of funding. Researchers will be able to electronically fill and submit an application through https://repository.diabetesaction.staging0.com (currently under development) or by contacting diabetes.repository@utoronto.ca

Data:

Data housed within the National Diabetes Repository are de-identified. Diabetes Action Canada has oversight of the use of the data through a robust Research Governing Committee.

Based on the project requirements, as outlined in a dataset creation plan, the Repository Data Manager will provide a cut of research data onto a secure virtual desktop for analysis.  This cut of data will be aligned with the REB approved research proposal reviewed and approved by the Research Governing Committee.

Analytic Workspace:

Researchers will have access to a suite of statistical programs.

It is important to note that the data provided will be restricted to the secure virtual desktop and cannot be removed from the environment.

Data Elements:

Allergy Intolerance Family History Medical Procedures
Disease Case Indicator Health Conditions Demographics
Diagnosis Laboratory Results Risk Factors
Encounter Medication Vaccine

 

Additional data elements may be available.  If interested, please request an updated data dictionary.

The launch of the Diabetes Action Canada National Diabetes Repository will enable unprecedented scientific insight into patient health, comorbidities and a deeper understanding of the mechanisms behind diabetes and its related complications.

Questions? Please contact conrad.pow@nygh.on.ca or diabetes.repository@utoronto.ca

Congratulations Michelle Greiver On Being Awarded a $2.6 Million Competitive Operating Grant

Diabetes Action Canada will like to congratulate  Dr. Michelle Greiver on being awarded a $2.6 million competitive operating grant. The grant will fund a SPIDER (Structured Process Informed by Data, Evidence and Research) approach, supporting primary care practices in optimizing care for patients with complex needs.

CLick here to read the full article published by  Canadian Health Care Technology

Recherche axée sur le patient (RAP) Mentorat des jeunes chercheurs en diabète et ses complications 2018-2019


Action diabète Canada lance son concours 2018-2019 de mentorat intercentre pour les jeunes chercheurs qui s’intéressent à la recherche axée sur le patient (RAP) dans le domaine du diabète et de ses complications. L’objectif de ce concours est de promouvoir le réseautage et l’intégration optimale des jeunes chercheurs au sein du réseau Action diabète Canada (ADC) et la communauté canadienne de recherche sur le diabète. Jusqu’à deux (2) bourses annuelles de seront attribuées aux jeunes chercheurs afin de travailler avec un mentor interne et un mentor externe. Le mentor interne sera affilié au même centre de recherche que le jeune chercheur. Le mentor externe sera affilié à un autre centre de recherche. Au moins un mentor sera membre régulier du réseau ADC. Les mentors qui ne sont pas des chercheurs principaux ou des co-chercheurs d’ACD doivent devenir membres d’ADC avant l’allocation des fonds.

 

Vous trouverez ci-joints les critères d’éligibilité et le processus d’évaluation ainsi que le formulaire de demande à compléter. Les candidats retenus recevront un soutien financier d’un maximum de 10 000 $ pour une période d’un an afin d’appuyer leurs activités scientifiques intercentres.

RAP Mentorat des jeunes chercheurs 2018-19

Formulaire de demande_RAP Mentorat des jeunes chercheurs 2018-19

Bonne chance à tous!


 

Patient-Oriented Research (POR) Early Career Investigator Mentorship Award in Diabetes and its Complications 2018-2019


Diabetes Action Canada is launching its 2018-2019 Intercentre Mentorship award for early career investigators interested in Patient-Oriented Research (POR) in diabetes and its complications. The goal of this award is to promote networking and optimal integration of early career investigators into the Diabetes Action Canada (DAC) Network and the Canadian diabetes research community. Up to two (2) annual mentorship awards will be awarded to early career investigators to work with an internal mentor and an external mentor. The internal mentor will be affiliated to the same research centre as the early career investigator. The external mentor will be affiliated with a different research centre from that of the early career investigator. At least one mentor will be a regular member of the DAC Network. Mentors who are not PI’s or Co-I’s of the DAC must become DAC members before the allocation of funds.

 

Please find attached the eligibility criteria and methods of evaluation and also the application form to complete. Successful candidates will receive financial support of a maximum of $10,000 for a one-year period to support their intercentre scientific activities.

Application form_POR Early Career Investigator Mentorship 2018-19

POR Early Career Investigator Mentorship 2018-19 (2)

Best of luck to all!

 


 

Recherche axée sur le patient (RAP) Stages étudiants intercentres en diabète et ses complications 2018-2019


Action diabète Canada lance son concours 2018-2019 de stages étudiants intercentre pour les étudiants au doctorat, les stagiaires postdoctoraux et les professionnels de recherche qui s’intéressent à la recherche axée sur le patient (RAP) dans le domaine du diabète et de ses complications. L’objectif de ce concours est de promouvoir le réseautage et l’intégration optimale des stagiaires dans le réseau Action diabète Canada (ADC) et la communauté canadienne de la recherche sur le diabète. Jusqu’à deux (2) octrois seront attribués annuellement. Le réseau ADC invite les chercheurs principaux ou co-chercheurs qui sont membres du réseau ADC à proposer des projets collaboratifs dans le domaine du diabète et de ses complications axés sur les patients et pour lesquels un stagiaire terminera sa formation dans un laboratoire dans un autre centre de recherche. Ce projet impliquera un chercheur principal ou un co-chercheur du réseau ADC et un ou plusieurs collaborateurs d’un autre centre de recherche. Chaque collaborateur doit être membre du réseau ADC (ou un autre réseau SPOR) et participer à ses activités.

 

Vous trouverez ci-joints les critères d’éligibilité et le processus d’évaluation ainsi que le formulaire de demande à compléter. Les candidats retenus recevront un soutien financier d’un maximum de 10 000 $ pour une période d’un an afin de permettre une collaboration entre les stagiaires et les collaborateurs.

POR Intercentre Trainee Internship 2018-19

Formulaire de demande_RAP Stages étudiants intercentres 2018-19

Bonne chance à tous!

 


 

Patient-Oriented Research (POR) Intercentre Trainee Internship Award in Diabetes and its Complications 2018-2019


Diabetes Action Canada is launching its 2018-2019 Intercentre Internship competition for graduate students, postdoctoral fellows, and research professionals interested in Patient-Oriented Research (POR) in diabetes and its complications. The goal of this award is to promote networking and optimal integration of trainees into the Diabetes Action Canada (DAC) Network and the Canadian diabetes research community. Up to two (2) annual internships will be awarded to trainees. The DAC Network invites researchers who are PI’s or Co-I’s of the DAC Network to propose collaborative projects in the areas of diabetes and its complications and for which a trainee will complete his training in another laboratory (in another research centre). This project will involve a DAC Network PI or Co-I with one or more collaborators of another Patient-Oriented Research centre. Every collaborator must be a member of the DAC Network (or another SPOR Network) and participate in its activities.

 

Please find attached the eligibility criteria and methods of evaluation, and also the application form to complete. Successful candidates will receive financial support of a maximum of $10,000 for a one-year period to allow the establishment of the trainee-based collaboration between the collaborators.

Application form_POR Intercentre Trainee Internship 2018-19

POR Intercentre Trainee Internship 2018-19

Best of luck to all!


 

Researchers have uncovered why only a subset of diabetic patients develop kidney disease -A Risk Uncovered

Kidney disease is a common complication for those living with diabetes and a leading cause of end-stage renal disease, other illnesses and death.  Not all individuals who have diabetes, including those diagnosed at an early age, develop kidney disease.   To understand why some individuals get kidney disease while other do not, a recent study by Diabetes Action Canada Investigators, Dr. Bruce Perkins and Dr. David Cherney in JCI  investigates the role of the renin-angiotensin-aldosterone system (RAAS) – a hormone system that regulates blood pressure and fluid balance.

The function of the kidney is to filter waste products from the blood, by removing them in the urine.  In people with diabetes, higher than normal blood glucose levels over a period of time can damage the blood vessels in the kidneys. If these blood vessels are not functioning properly than the kidney is unable to filter toxins effectively and this can lead kidney disease.  If left untreated, this can lead to kidney failure and the need for either dialysis or a kidney transplant.

In this study, 75 people living with prolonged type-1 diabetes (T1D) and 75 people living without diabetes were tested before and after RAAS stimulation.  Of the individuals with T1D and no signs of kidney damage RAAS activity was comparable to individuals without diabetes.  Conversely, individuals with diabetes and signs of kidney disease had higher levels of RAAS hormone activity causing the the arteries that supply blood to the kidney to constrict.  This study outcome could suggest that that RAAS activation could be an important marker for kidney dysfunction, especially in patients with long-term diabetes.

This work was supported by JDRF and the Toronto General & Western Hospital Foundation.

Lovshin JA, Boulet G, Lytvyn Y, Lovblom LE, Bjornstad P, Farooqi MA, Lai V, Cham L, Tse J, Orszag A, Scarr D, Weisman A, Keenan HA, Brent MH, Paul N, Bril V, Perkins BA, Cherney DZ.
Renin-angiotensin-aldosterone system activation in long-standing type 1 diabetes (link is external). JCI Insight. 2018 Jan 11. doi: 10.1172/jci.insight.96968

Diabetes Action Canada: A paradigm shift in Research – as featured in UofT IMS Magazine

Diabetes Action Canada: A paradigm shift in Research – the title of a recent article about our SPOR Network in chronic disease written by Erika Opingari and published in IMS Magazine at University of Toronto.

This article provides an excellent overview of Diabetes Action Canada and our contribution to developing a patient-informed learning health system.

To read more click here: IMS Magazine Winter 2018; Diabetes Action Canada

 

McGill announces Dr. Jean-Pierre Després as the 2018 Winner of the Manulife Prize for the Promotion of Active Health

McGill University, in association with Manulife and the McGill Centre for the Convergence of Health and Economics (MCCHE), is pleased to announce that Dr. Jean-Pierre Després, Professor at the Department of Kinesiology, Faculty of Medicine at Université Laval and pioneer in developing screening techniques for visceral obesity, is the winner of the 2018 Manulife Prize for the Promotion of Active Health.  This award recognises research pioneers who screened for abdominal obesity and acted to prevent it.

With over 30 years of experience, Dr. Després is recognised for being the first to suggest that individuals with visceral obesity (characterized by an excess accumulation of body fat in the abdominal region) are at the highest risk for diabetes and cardiovascular disease. In line with these findings, he developed a novel approach to screen for visceral obesity. He determined that the combination of a high waist circumference with elevated blood triglycerides was predictive of an 85% chance of being diagnosed with visceral obesity – a screening approach that has been widely accepted by the international medical community.

To read more please visit this link

JOINT IAS-ICCR SATELLITE SYMPOSIUM


ABOUT THE SYMPOSIUM

There is considerable evidence from several imaging cardiometabolic studies that excess visceral adipose tissue accumulation is associated with a constellation of cardiometabolic abnormalities for which hypertriglyceridemia is a key feature. This satellite symposium will provide an update on visceral obesity as a clinical entity requiring new tools for clinical assessment and management. It will also provide evidence that the hypertriglyceridemia of visceral obesity is particularly atherogenic as it reflects atherogenic dysfunctions in subcutaneous adipose tissue and lipoprotein metabolism, leading to the formation of atherogenic remnants. Therapeutic and preventive options will also be reviewed.

This IAS/ICCR joint satellite symposium is supported by an unrestricted grant from Kowa Company, Ltd.

SYMPOSIUM DETAILS

Date: Wednesday, June 13, 2018
Time: 08:30 – 17:30
Location: Room 717, Metro Toronto Convention Centre (MTCC)

 

CLICK HERE TO REGISTER